Paradigm Diagnostics

About:

Paradigm is a private molecular information corporation established to bring cutting-edge diagnostics to cancer patients and industry.

Website: http://www.paradigmdx.com/

Twitter/X: paradigm_dx

Top Investors: Tech Coast Angels, New Science Ventures, BlueStone Venture Partners, Mesa Verde Venture Partners, Gore Range Capital

Description:

Paradigm brings cutting-edge diagnostics and biomarker driven clinical trials to benefit cancer patients.Through Next-Gen Sequencing, and other biomarker analysis, Paradigm is able to provide information about the genomic and proteomic landscape of a patient’s cancer, as well as potential therapies based on the specific characterization of the patient’s tumor; thus, personalizing each patient’s course of treatment.